Page last updated: 2024-10-24

high-density lipoprotein particle remodeling

Definition

Target type: biologicalprocess

The acquisition, loss or modification of a protein or lipid within a high-density lipoprotein particle, including the hydrolysis of triglyceride by hepatic lipase, with the subsequent loss of free fatty acid, and the transfer of cholesterol esters from LDL to a triglyceride-rich lipoprotein particle by cholesteryl ester transfer protein (CETP), with the simultaneous transfer of triglyceride to LDL. [GOC:BHF, GOC:expert_pt, GOC:mah, GOC:rl]

High-density lipoprotein (HDL) particle remodeling is a dynamic process involving changes in the size, composition, and structure of HDL particles, contributing to their diverse functions in lipid metabolism and reverse cholesterol transport (RCT). This process involves a series of enzymatic reactions and interactions with other lipoproteins and cells, ultimately influencing the efficiency of cholesterol removal from peripheral tissues and delivery to the liver.

**Initial Formation and Composition:**

HDL particles are initially assembled in the liver and intestines as nascent HDL (pre-beta HDL) particles. These nascent particles are small and have a high content of apolipoprotein A-I (apoA-I), a major structural protein of HDL. They also contain small amounts of other lipids, such as cholesterol esters (CE) and phospholipids.

**Enzymatic Modifications and Lipid Exchange:**

Nascent HDL particles undergo enzymatic modifications and lipid exchange interactions with other lipoproteins and cells. These modifications contribute to the maturation of HDL particles and their ability to acquire cholesterol from peripheral tissues.

* **Lecithin:cholesterol acyltransferase (LCAT):** LCAT is an enzyme that catalyzes the esterification of cholesterol in HDL particles. This reaction converts free cholesterol to CE, which increases the capacity of HDL to carry cholesterol. LCAT activity is enhanced by apoA-I and requires the presence of phospholipids.

* **Cholesterol ester transfer protein (CETP):** CETP mediates the transfer of CE from HDL to other lipoproteins, such as very-low-density lipoprotein (VLDL) and low-density lipoprotein (LDL). This transfer process is important for the delivery of cholesterol to tissues and contributes to the removal of cholesterol from HDL.

* **Phospholipid transfer protein (PLTP):** PLTP facilitates the exchange of phospholipids between HDL and other lipoproteins. This exchange process contributes to the formation of mature HDL particles with optimal lipid composition.

* **Lipoprotein lipase (LPL):** LPL hydrolyzes triglycerides (TG) in VLDL and chylomicrons, releasing free fatty acids. These fatty acids can be taken up by HDL particles, contributing to the formation of larger, more mature HDL particles.

**Cholesterol Acquisition and Reverse Cholesterol Transport:**

Mature HDL particles, now enriched in CE, have the capacity to acquire cholesterol from peripheral tissues. This process is crucial for RCT, the pathway responsible for removing cholesterol from the body.

* **Apolipoprotein A-I (apoA-I):** ApoA-I plays a key role in mediating the interaction of HDL with cell membranes. It binds to scavenger receptor class B type 1 (SR-BI), a receptor on the surface of cells, facilitating cholesterol efflux.

* **ABCA1:** ABCA1 is a transporter protein expressed in the liver, intestines, and other tissues. It promotes the efflux of free cholesterol from cells to HDL particles.

* **ATP-binding cassette transporter G1 (ABCG1):** ABCG1 is another transporter protein that contributes to cholesterol efflux from cells to HDL. It preferentially transports cholesterol esters.

**Delivery to the Liver and Excretion:**

HDL particles carrying cholesterol eventually deliver their cargo to the liver.

* **Hepatic lipase (HL):** HL hydrolyzes CE in HDL particles, releasing free cholesterol.

* **SR-BI:** HDL particles interact with SR-BI on the surface of hepatocytes, leading to the delivery of cholesterol to the liver.

* **Bile acid synthesis:** Cholesterol delivered to the liver can be converted into bile acids, which are excreted in the feces.

**Factors Influencing HDL Remodeling:**

Several factors can influence HDL remodeling, including:

* **Genetics:** Polymorphisms in genes encoding apoA-I, LCAT, CETP, and other proteins involved in HDL metabolism can affect HDL particle size and composition.

* **Lifestyle factors:** Diet, exercise, smoking, and alcohol consumption can influence HDL levels and remodeling.

* **Disease states:** Conditions such as diabetes, hyperlipidemia, and cardiovascular disease can disrupt HDL remodeling.

**Clinical Significance:**

HDL remodeling is a crucial process in maintaining lipid homeostasis and preventing atherosclerosis. Disruptions in HDL remodeling can lead to increased cholesterol levels, reduced RCT, and an elevated risk of cardiovascular disease. Understanding the complex mechanisms of HDL remodeling is essential for developing strategies to target HDL metabolism and improve cardiovascular health.'
"

Proteins (8)

ProteinDefinitionTaxonomy
Phosphatidylcholine-sterol acyltransferaseA phosphatidylcholine-sterol acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04180]Homo sapiens (human)
Lipoprotein lipaseA lipoprotein lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P06858]Homo sapiens (human)
Endothelial lipaseAn endothelial lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y5X9]Homo sapiens (human)
Group 3 secretory phospholipase A2A group 3 secretory phospholipase A2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NZ20]Homo sapiens (human)
Scavenger receptor class B member 1A scavenger receptor class B member 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8WTV0]Homo sapiens (human)
Cholesteryl ester transfer proteinA cholesteryl ester transfer protein that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11597]Homo sapiens (human)
Hepatic triacylglycerol lipaseA hepatic triacylglycerol lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P11150]Homo sapiens (human)
Phosphatidylcholine-sterol acyltransferaseA phosphatidylcholine-sterol acyltransferase that is encoded in the genome of human. [PRO:DNx, UniProtKB:P04180]Homo sapiens (human)

Compounds (25)

CompoundDefinitionClassesRoles
niacinNiacin: A water-soluble vitamin of the B complex occurring in various animal and plant tissues. It is required by the body for the formation of coenzymes NAD and NADP. It has PELLAGRA-curative, vasodilating, and antilipemic properties.

nicotinic acid : A pyridinemonocarboxylic acid that is pyridine in which the hydrogen at position 3 is replaced by a carboxy group.

vitamin B3 : Any member of a group of vitamers that belong to the chemical structural class called pyridines that exhibit biological activity against vitamin B3 deficiency. Vitamin B3 deficiency causes a condition known as pellagra whose symptoms include depression, dermatitis and diarrhea. The vitamers include nicotinic acid and nicotinamide (and their ionized and salt forms).
pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3
antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
rimcazolerimcazole: RN given refers to (cis)-isomer; structure given in first sourcecarbazoles
ursolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
geroprotector;
plant metabolite
3-octylthio-1,1,1-trifluoro-2-propanone3-octylthio-1,1,1-trifluoro-2-propanone: a pesticide synergist; inhibits juvenile hormone esterase
varespladibaromatic ether;
benzenes;
dicarboxylic acid monoamide;
indoles;
monocarboxylic acid;
primary carboxamide
anti-inflammatory drug;
antidote;
EC 3.1.1.4 (phospholipase A2) inhibitor
torcetrapib(trifluoromethyl)benzenes;
carbamate ester;
quinolines
anticholesteremic drug;
CETP inhibitor
sb 203580imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
nutlin 3stilbenoid
delta-8-tetrahydrocannabinol1-benzopyran
orlistatorlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug.

Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.
beta-lactone;
carboxylic ester;
formamides;
L-leucine derivative
anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: structure in first source

alvespimycin : A 19-membered macrocyle that is geldanamycin in which the methoxy group attached to the benzoquinone moiety has been replaced by a 2-(N,N-dimethylamino)ethylamino group.
1,4-benzoquinones;
ansamycin;
carbamate ester;
secondary amino compound;
tertiary amino compound
Hsp90 inhibitor
tanespimycinCP 127374: analog of herbimycin A1,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound
antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
dalcetrapibdalcetrapib: inhibits cholesteryl ester transfer protein (CETP)anilide
am-411
sc 795
3-((3-(4-chloro-3-ethylphenoxy)phenyl)(3-(1,1,2,2-tetrafluoroethoxy)benzyl)amino)-1,1,1-trifluoropropan-2-ol3-((3-(4-chloro-3-ethylphenoxy)phenyl)(3-(1,1,2,2-tetrafluoroethoxy)benzyl)amino)-1,1,1-trifluoropropan-2-ol: inhibits cholesteryl ester transfer protein; structure in first source
amg 3AMG 3: structure in first source
km-233KM-233: used for the treatment of high-grade glioma; structure in first source
mk 0354
anacetrapib
humaninhumanin: suppresses neuronal cell death induced by the Swedish mutant of amyloid precursor protein; suppresses neuronal cell death induced by three different types of FAD genes and amyloid beta; amino acid sequence in first source
gdc 0941pictrelisib : A sulfonamide composed of indazole, morpholine, and methylsulfonyl-substituted piperazine rings bound to a thienopyrimidine ring.indazoles;
morpholines;
piperazines;
sulfonamide;
thienopyrimidine
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
skepinone-lskepinone-L: a dibenzosuberone-type p38 MAPK inhibitor; structure in first source
evacetrapibbenzazepine
xen445